MedPath

Transcutaneous bilirubin measurement: The comparison of the reliability of transcutaneous bilirubin measurement in comparison to a measurement of plasma.

Recruiting
Conditions
neonaten die icterisch zien en geprikt worden op hyperbilirubinemie. icteric neonates who will be pinned on hyperbilirubinaemia.
Registration Number
NL-OMON20391
Lead Sponsor
Judith DemmersOmloop 684614 ER, Bergen op ZoomThe Netherlandsjdemmers@amphia.nl076-5951575 / 076-5951591 / 06-14683021
Brief Summary

/A

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Not specified
Target Recruitment
60
Inclusion Criteria

Neonates between 32-42 weeks gestation in which we want to determine a bilirubin.

Exclusion Criteria

1. Neonates < 32 weeks of gestation;

2. Neonates with blood type antagonism;

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Bilirubine levels of the two transcutaneous devices en the measurement from the serum.
Secondary Outcome Measures
NameTimeMethod
Comparing of the bilirubine levels from the different devices and their sensitivity en specificity.
© Copyright 2025. All Rights Reserved by MedPath